FDC receives US FDA approval for Timolol Maleate eye solution

New Delhi, May 9 (UNI) Leading pharmaceutical firm FDC Ltd today said it has received the US Food and Drug Administration approval for its Timolol Maleate eye solution.

Timolol Maleate Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma, a company statement said.

Mumbai-based FDC Ltd's products include formulations and active pharmaceutical ingredients (APIs).

The company exports its products to about 50 countries, including the US, South Africa, United Kingdom, Europe, and Japan.

UNI SR AK DS1402